Skip to content

Public FDA record

Z-0319-2027: Embletta MPR PG Multi Parameter Recorder Sleep Monitor, Model/Catalog Number: 2003011

Recall record Z-0319-2027 for NATUS MEDICAL INCORPORATED. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0319-2027
Company in FDA record
NATUS MEDICAL INCORPORATED
FDA classification date
Oct 30, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Class II

Reason stated in the source

The device may be unable to correctly format its internal memory. When the internal memory cannot be correctly formatted, previously recorded studies may remain on the device and may be updated with incorrect patient information from a subsequent study. The issue may also prevent studies from initiating recording successfully or may cause recordings to end prematurely, resulting in incomplete or unavailable diagnostic data and the potential need to repeat a patient study.

Source facts

Action
An Urgent Medical Device Field Correction notification letter was sent to customers beginning 9/29/26. ACTION: " Review the serial numbers in this notice and identify any affected devices that are currently in your possession. " Immediately cease use of the affected product and quarantine until you receive further instructions from Natus for correcting the affected device(s). " Review all studies recorded on affected Embletta MPR devices to verify that patient information is correctly associated with the corresponding study and that the study data are complete, accurate, and attributable to the intended patient. " Please complete the enclosed form and return to FCA@Natus.com. If you have affected product, you will receive instructions on how to correct your affected Embletta MPR PG device(s) from FCA@Natus.com. All corrections will be provided at no cost to you. " If you do not have affected product, please respond to confirm no further actions are required. " Adverse reactions or quality problems experienced with the use of the part should be reported to Natus and the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax. " Complete and submit the report Online at www.fda.gov/medwatch/report.htm. " Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178. RESOLUTION Investigation results have determined that the issue is caused by a recent change to the internal memory within the affected Embletta MPR devices. The corrective action is currently being finalized. Customers with affected devices should contact Natus using the information provided above. Natus will provide the necessary instructions to complete the corrective action. If you have any questions regarding this notice, please contact FCA@Natus.com.
Initiated
2026-09-29
Root cause
Component change control
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, China, Italy, Portugal.
Recall number
Z-0319-2027
Recall status
Open, Classified
CDRH record ID
222948
FDA classified
2026-10-30
Recall event number
99941

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗